- Medicine Name: Ngenla
- Generic Name: Somatrogon-ghla
- Dosage Form & Strength: Injections: 24 mg/1.2 mL (20 mg/mL) & 60 mg/1.2 mL (50 mg/mL) single-patient-use prefilled pen
- Manufactured By: Pfizer Pharmaceuticals
Ngenla (somatrogon-ghla) is a once-weekly human growth hormone (hGH) analog used in the treatment of pediatric patients aged three years and more who have growth failure because of poor secretion of endogenous growth hormone.
Recommended Dosage: The recommended dosage of Ngenla injection is 0.66 mg per kg based on actual body weight administered once weekly by subcutaneous (SC) injection, on the same day every week, at any time of the day in the upper arms, abdomen, buttocks, or thighs.
The dosage can be individualized for each patient on behalf of the growth response. If necessary, the day of weekly administration can be changed as long as the time between a couple of doses is at least 3 days. After considering a fresh dosing day, the once-weekly dosing should be continued. When switching from daily growth hormone, the once-weekly dose may be started on the day after their final daily injection. If more than 1 injection is needed to deliver a complete dose, each injection needs to be administered at a dissimilar injection site.
If a dose is missed, administer it as quickly as possible within 3 days following the missed dose. If more than 3 days have elapsed, skip the missed dose and administer the next scheduled dose on the regularly scheduled day.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.